Select Page
GSK Headed to Regulators with RSV Vaccine

GSK Headed to Regulators with RSV Vaccine

The pursuit for an effective vaccine against the respiratory syncytial virus (RSV) may be at an inflection point. GlaxoSmithKline disclosed positive headline data Friday from a pre-specified efficacy interim analysis of the Phase III trial of its RSV vaccine. The...